3USL

WisdomTree S&P 500 3x Daily Leveraged

ETFs & Funds · USD · LSE

3USLETFT212

Price

$183.99

+4.99%

Cap

Earnings

30d Trend

+1.1%

3USL
Loading chart data...
0 days · % change from startPowered by Brain47
52-week range94%
$101.29$189.15

Near 52-week highs — limited upside before resistance

VolatilityHigh

42% annualised over 90 days

BRAIN47 SIGNAL

0
STRONG
Risk Level58
Quality50
Momentum82
Technical52
Fundamentals50

Raw weighted: 66×Macro 0.99 (1%)=65

RISK LEVEL

58/100
90d Volatility
41.9%High
ATR %
3.2%High daily moves
Max Drawdown (1Y)
-25.3%Normal

QUALITY

50/100

MOMENTUM

82/100
6-1M Momentum
+25.9%Positive
1M Return
-0.8%Stable

TECHNICAL

52/100
RSI (14)
52.1Neutral
Price vs SMA200
+19.2%Bullish trend
MACD
-2.80Bearish momentum
Bollinger Band
40%Mid-range
SMA Cross
Death CrossDeath Cross
Trend Quality (KER)
0.100Noisy/choppy

FUNDAMENTALS

50/100

Macro: neutral (×0.99) - Fear/Greed: 61 (Greed) - Data: 60%

Running historical backtest...

BRAIN47 HORIZON ANALYSIS

<3 months44
3-12 months83
1-5+ years48

6-9 month momentum thesis — strong trend with confirmation

BRAIN47'S ASSESSMENT

I rate WisdomTree S&P 500 3x Daily Leveraged at 65/100 — a STRONG reading on the Brain47 Signal. The strongest factor is momentum at 82/100. I classify this as a growth position with the strongest thesis on a medium-term horizon.

PAST PERFORMANCE

1 MONTH

-0.8%

3 MONTHS

+30.5%

12 MONTHS

Trailing returns — past performance, not a projection.

DETAILED ANALYSIS

6-9 month momentum thesis — strong trend with confirmation. Momentum (82) and Technical (52) are the primary strengths. I note an elevated risk profile — this warrants closer monitoring. Historical volatility is elevated at 42%. I classify this as a growth position — strong momentum combined with growth potential points to capital appreciation.

growthScore: 65/100

Want full analysis on every stock?

Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.

Join Brain47 — Free

Generated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.